Cleveland Clinic

ADT and other mainstays of therapy for men with castration-resistant prostate cancer may be effective in the management of Skene’s gland malignancy, a rare paraurethral adenocarcinoma.

Kidney transplant surgeon Alvin Wee, MD, MBA, presented findings at the 2022 AUA Annual Meeting

Minimally invasive BPH procedures relieve symptoms and can be done in outpatient settings.

On this episode of Cleveland Clinic’s Cancer Advances podcast, Byron Lee, MD, PhD, discusses optimizing surgical options for patients with bladder cancer.

A 54-year-old transgender woman presented at Cleveland Clinic with vaginal stenosis. She was seeking surgical revision after complications from gender affirmation surgeries performed at other care centers failed to establish a functional neovagina.

Cleveland clinic physicians Rahul Tendulkar, MD, and Steve Huang, MD, provide expert insight on PSMA-PET imaging and explain how it has changed clinical management of patients with prostate cancer.

Surgeons use single-port robot to achieve transvesical access to the vagina.

“Using the single-port robot with the transvesical approach allows us to go directly into the bladder, this means that we avoid the intraperitoneal cavity, which is not feasible with the multiport approach. This has led to less pain and postoperative ileus because the bowels stay intact,” says Jihad Kaouk, MD.

On this episode of Cleveland Clinic’s Cancer Advances podcast, Zeyad Schwen, MD, discusses transperineal biopsy and advancements in screening for prostate cancer.

Analysis is one of the largest-ever series of outcomes for patients with renal masses in a solitary kidney.

“Our algorithms were extremely accurate in predicting treatment response to both modalities. In fact, they could correctly predict which patient was a responder and which patient was a non-responder about 90% of the time in patients they had never seen before,” said Glenn Werneburg, MD, PhD.

“We know that, in general, cystectomy in women can disrupt pelvic floor support and innervation, as well as hormonal and sexual function, but there are no good prospective data to help us fully understand pelvic floor complications following the procedure,” said Jacqueline Zillioux, MD.

On this episode of Cleveland Clinic’s Cancer Advances podcast, Christopher Weight, MD, discusses high-intensity focused ultrasound for treating patients with localized prostate cancer.

“This study really shows the power of the area deprivation index in predicting postoperative and oncologic outcomes for bladder cancer patients undergoing radical cystectomy,” said Byron H. Lee, MD, PhD, Cleveland Clinic urologist and senior author of the study.

Cleveland Clinic’s Petar Bajic, MD, details updated joint guidance from the AUA and SMSNA on the management of acute ischemic priapism.

On this episode of Cleveland Clinic’s Cancer Advances podcast, Sarah Vij, MD, discusses the different fertility-sparing techniques used for both pre-pubertal and post-pubertal male cancer patients.

On this episode of Cleveland Clinic’s Cancer Advances podcast, Eric Klein, MD, discusses the novel IsoPSA test and how it differs from conventional PSA testing.

Experts at the Cleveland Clinic are assessing standard surgical approaches in bladder cancer and identifying new ones.

These research and technology breakthroughs are designed to improve outcomes and the patient experience.

On this episode of Cleveland Clinic’s Cancer Advances podcast, urologic surgeon Steven Campbell, MD, PhD, discusses the longstanding controversy between partial nephrectomy and radical nephrectomy for patients with localized kidney cancer.

Researchers uncover how diet, lifestyle modifications may lower risk of lethal disease.

New findings could shape the treatment paradigm for a select group of bladder cancer patients.